Stock Market Update

[BRIEFING.COM] The S&P 500 (+0.1%), Nasdaq Composite (+0.1%), and DJIA (-0.1%) remain little changed from previous levels amid a sleepy session for the market.

Though not a component of the S&P 500, Novo Nordisk A/S (NVO 62.13, +5.01, +8.77%) trades sharply higher today.  CNBC attributes the gains to a "solid start" for the company's launch of its GLP-1 weight loss pill in the U.S., which officially launched on January 5. 

Eli Lilly (LLY 1043.50, +10.53, +1.02%), which is seen as a direct competitor, also trades higher today, though the stock fell sharply yesterday after the FDA postponed an approval decision of the company's own weight loss drug to April 10.